David Tanen

David Tanen

Founder presso KRONOS BIO, INC.

Patrimonio netto: 1 M $ in data 31/03/2024

52 anni
Health Technology
Finance
Consumer Services

Provenienza dei contatti di primo grado di David Tanen

EntitàTipo di entitàSettore Industriale
Public Company Pharmaceuticals: Major 29
Public Company Pharmaceuticals: Major 20
15
Private Company Investment Managers 15
13
Private Company Investment Managers 13
11
Subsidiary Biotechnology 11
9
Holding Company Pharmaceuticals: Major 9
Nile Therapeutics, Inc. /Old/
8
Extinct Pharmaceuticals: Major 8
8
Private Company Biotechnology 8
Public Company Pharmaceuticals: Major 7
6
Holding Company Pharmaceuticals: Major 6
5
Private Company Investment Managers 5
3
Subsidiary Investment Banks/Brokers 3
Two Rivers Consulting Corp.
1
Private Company 1
Two River Group Management LLC
1
Private Company 1
1
Private Company Miscellaneous Commercial Services 1

Grafico delle società connesse in secondo grado

Relazione in diverse aziende

Società connesse a David Tanen tramite i suoi contatti personali

SocietàSettorePersone collegatePosizione principale
AMGEN INC. Pharmaceuticals: Major

Scott Fields

David Chang

Roshawn Blunt

Corporate Officer/Principal

Private Equity Investor

General Counsel

BRISTOL-MYERS SQUIBB COMPANY Pharmaceuticals: Major

Jay Moorin

John Martin

F. Allan Gordon

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Biotechnology

Norbert W. Bischofberger

Franz Humer

Hsiao Lieu

Jorge DiMartino

Corporate Officer/Principal

Director/Board Member

Corporate Officer/Principal

Chief Tech/Sci/R&D Officer

GILEAD SCIENCES, INC. Biotechnology

Tai Yin Yang

John Martin

Norbert W. Bischofberger

Phillip Gutry

Roger Dansey

Marni Kottle

Corporate Officer/Principal

Chief Executive Officer

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

Corporate Officer/Principal

Public Communications Contact

ELI LILLY AND COMPANY Pharmaceuticals: Major

Pedro Granadillo

Edmundo Manuel Muniz

Anne White

Hsiao Lieu

Human Resources Officer

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

PFIZER, INC. Pharmaceuticals: Major

Tyana Kurtz

J. Chris Houchins

Yordak Salermo

Sales & Marketing

Corporate Officer/Principal

Corporate Officer/Principal

VIOQUEST PHARMACEUTICALS, INC. Pharmaceuticals: Other

Stephen Rocamboli

Brian Lenz

Michael Weiser

Chairman

Director of Finance/CFO

Director/Board Member

TG THERAPEUTICS, INC. Pharmaceuticals: Major

Joshua Kazam

Tim McInerney

Michael Weiser

Director/Board Member

Director/Board Member

Director/Board Member

Biotechnology

Fred Cohen

Katherine Wood

Arjun Goyal

Marianne de Backer

Director/Board Member

Director/Board Member

Director/Board Member

Director/Board Member

Miscellaneous Commercial Services

John Martin

Barbara Kosacz

Mark Pruzanski

Director/Board Member

Director/Board Member

Director/Board Member

NGM BIOPHARMACEUTICALS, INC. Biotechnology

Helen Kim

Barbara Kosacz

Hsiao Lieu

Consultant / Advisor

Corporate Secretary

Chief Tech/Sci/R&D Officer

PELOTON THERAPEUTICS, INC. Pharmaceuticals: Major

Helen Kim

David Chang

Arjun Goyal

Director/Board Member

Director/Board Member

Director/Board Member

Investment Managers

Fred Cohen

Stefan Vitorovic

Katherine Wood

Private Equity Investor

Private Equity Analyst

Private Equity Investor

College/University

Tomer Kariv

Dinah Sah

Angela Koehler

Undergraduate Degree

Doctorate Degree

Doctorate Degree

Stanford University College/University

Fred Cohen

Barbara Kosacz

Owen N. Witte

David Chang

Stefan Vitorovic

Katherine Wood

Rachel Mears

Marni Kottle

Doctorate Degree

Undergraduate Degree

Doctorate Degree

Doctorate Degree

Graduate Degree

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

University of Pennsylvania College/University

Peter M. Strumph

William F. Hamilton

Peter Morgan Kash

Elena Ridloff

Undergraduate Degree

Corporate Officer/Principal

Corporate Officer/Principal

Undergraduate Degree

University of Oxford College/University

Martin Murphy

Fred Cohen

Yasir Al-Wakeel

Arjun Goyal

Undergraduate Degree

Doctorate Degree

Doctorate Degree

Undergraduate Degree

University of Cambridge College/University

Martin Murphy

Yasir Al-Wakeel

Arjun Goyal

Doctorate Degree

Graduate Degree

Graduate Degree

Orion Biomedical Fund LP

Joshua Kazam

Stephen Rocamboli

Peter Morgan Kash

Chief Investment Officer

Corporate Officer/Principal

Corporate Officer/Principal

Massachusetts Institute of Technology College/University

K. Wittrup

Dinah Sah

David Chang

Eric Trac

Charles Lin

Corporate Officer/Principal

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

Doctorate Degree

Yale University College/University

Fred Cohen

Marc Besman

Heba Nowyhed

Undergraduate Degree

Doctorate Degree

Doctorate Degree

College/University

Roger Glen Berlin

Barrett Katz

Owen N. Witte

Joseph Bisaha

Katherine Stultz

Doctorate Degree

Corporate Officer/Principal

Undergraduate Degree

Doctorate Degree

Undergraduate Degree

College/University

K. Wittrup

Rebecka Belldegrun

Doctorate Degree

Director/Board Member

New York University College/University

Mark Dana Zand

Barrett Katz

Hsiao Lieu

Masters Business Admin

Corporate Officer/Principal

Undergraduate Degree

Princeton University College/University

Ben Bernstein

Roshawn Blunt

Snyder Alexandra

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

University of Michigan College/University

Jay Moorin

Mark Dana Zand

Anne White

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

The Presidential Advisory Council on HIV/AIDS General Government

John Martin

Glenn Mattes

Corporate Officer/Principal

Corporate Officer/Principal

KITE PHARMA INC Biotechnology

Joshua Kazam

Arie Belldegrun

Helen Kim

Franz Humer

Steven Ruchefsky

Christine Cassiano

Scott L. Navins

Owen N. Witte

James S. Economou

David Chang

Founder

Chief Executive Officer

Private Equity Investor

Director/Board Member

Director/Board Member

Investor Relations Contact

Comptroller/Controller/Auditor

Director/Board Member

Founder

Private Equity Investor

David Geffen School of Medicine College/University

Arie Belldegrun

Owen N. Witte

David Chang

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

UROGEN PHARMA LTD. Biotechnology

Arie Belldegrun

Fred Cohen

Christine Cassiano

Kate Bechtold

Chairman

Director/Board Member

Consultant / Advisor

Director/Board Member

The Wharton School of the University of Pennsylvania College/University

Joshua Kazam

Peter M. Strumph

William F. Hamilton

Phillip Gutry

Christopher Wilfong

Corporate Officer/Principal

Masters Business Admin

Corporate Officer/Principal

Masters Business Admin

Undergraduate Degree

Harvard Business School College/University

Stefan Vitorovic

Katherine Wood

Arjun Goyal

Jean-Philippe Kouakou-Zebouah

Masters Business Admin

Masters Business Admin

Masters Business Admin

Masters Business Admin

Biotechnology

Arie Belldegrun

Fred Cohen

David Chang

Director/Board Member

Founder

Corporate Officer/Principal

Investment Managers

Joshua Kazam

Fred Cohen

David Chang

Stefan Vitorovic

Founder

Founder

Director/Board Member

Founder

TFF PHARMACEUTICALS, INC. Pharmaceuticals: Major

Randy Thurman

Stephen Rocamboli

Glenn Mattes

Director/Board Member

Director/Board Member

Chief Executive Officer

ALLOGENE THERAPEUTICS, INC. Biotechnology

Joshua Kazam

Arie Belldegrun

Franz Humer

Christine Cassiano

Owen N. Witte

David Chang

Founder

Founder

Director/Board Member

General Counsel

Director/Board Member

Founder

Miscellaneous Commercial Services

Helen Kim

David Chang

Jakob Loven

Director/Board Member

Director/Board Member

Director/Board Member

KYVERNA THERAPEUTICS, INC. Biotechnology

Fred Cohen

Stefan Vitorovic

Heba Nowyhed

Director/Board Member

Director/Board Member

Director/Board Member

Investment Managers

Joshua Kazam

Arie Belldegrun

Rebecka Belldegrun

Director/Board Member

Chairman

Director/Board Member

Biotechnology

Joshua Kazam

Arie Belldegrun

Helen Kim

David Chang

Jakob Loven

Founder

Founder

Director/Board Member

Chairman

Director/Board Member

Investment Managers

Christopher Dinsmore

Stefan Vitorovic

Ton Schumacher

Jakob Loven

Corporate Officer/Principal

Private Equity Investor

Private Equity Investor

Corporate Officer/Principal

New York University School of Medicine College/University

Michael Weiser

David Guyer

Doctorate Degree

Corporate Officer/Principal

Medical Specialties

Mark Dana Zand

Paul Anthony Mieyal

Director/Board Member

Director/Board Member

Statistiche

Distribuzione geografica

Stati Uniti 49
Regno Unito 3

Settori

Health Technology 24
Consumer Services 16
Finance 9
Commercial Services 3
Government 2

Posizioni

Director/Board Member 566
Corporate Officer/Principal 234
Independent Dir/Board Member 121
Chairman 108
Founder 100